# SPINK4

## Overview
SPINK4 is a gene that encodes the serine peptidase inhibitor Kazal type 4, a protein involved in the regulation of protease activity within the gastrointestinal tract. This protein is categorized as a serine protease inhibitor and plays a crucial role in maintaining mucosal homeostasis by modulating proteolytic processes. The SPINK4 protein interacts with the epidermal growth factor receptor (EGFR), influencing key signaling pathways such as Ras-MAPK and AKT, which are essential for cell proliferation and differentiation (Wang2024Therapeutic). Additionally, SPINK4 is implicated in the regulation of epithelial regeneration and differentiation, particularly in the context of inflammatory bowel diseases and colorectal cancer, where its expression levels are altered (Hu2023SPINK4; Wang2019Downregulated). The gene's expression and its interactions with other molecular pathways underscore its potential as a biomarker and therapeutic target in gastrointestinal disorders.

## Function


## Clinical Significance
Alterations in the expression of the SPINK4 gene have been implicated in several gastrointestinal diseases and cancers. In colorectal cancer (CRC), SPINK4 expression is significantly downregulated in tumor tissues compared to normal tissues, and this reduction is associated with poor survival outcomes for patients. The downregulation of SPINK4 in CRC is linked to increased cell proliferation, invasion, and migration, suggesting its role as a potential tumor suppressor (Wang2019Downregulated; Yang2024&lt; i&gt; SPINK4). Conversely, high SPINK4 expression is associated with poor outcomes in rectal cancer patients undergoing concurrent chemoradiotherapy (CCRT), indicating its potential role in treatment resistance (Chen2021High).

SPINK4 is also involved in inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn's disease. Its expression is increased in the colon mucosa of IBD models, and it plays a role in maintaining mucosal integrity and promoting goblet cell differentiation, which is crucial for gut defense (Hu2023SPINK4; Wang2024Therapeutic). In celiac disease, SPINK4 expression is elevated in active disease states and decreases with recovery, suggesting its involvement in disease pathogenesis (Wapenaar2007The). These findings highlight SPINK4's potential as a biomarker and therapeutic target in various gastrointestinal conditions.

## Interactions
SPINK4 interacts with the epidermal growth factor receptor (EGFR), playing a significant role in the regulation of intestinal epithelial regeneration. SPINK4 binds to the extracellular domain of EGFR, influencing downstream signaling pathways such as the Ras-MAPK and AKT pathways, which are crucial for cell proliferation and differentiation (Wang2024Therapeutic). This interaction is characterized by SPINK4's ability to compete with epidermal growth factor (EGF) for binding to EGFR, although the interaction is relatively weak (Wang2024Therapeutic).

SPINK4's interaction with EGFR also affects the Wnt/β-catenin and Hippo pathways, which are important for epithelial cell differentiation and regeneration (Wang2024Therapeutic). The binding of SPINK4 to EGFR is modulated by microbiota-derived components, such as the diacylated lipoprotein Pam2CSK4, which enhances SPINK4 expression and its subsequent effects on epithelial regeneration (Wang2024Therapeutic).

In addition to its interaction with EGFR, SPINK4 is involved in a feedback loop with PTGER4 signaling, which regulates its mRNA levels and promotes goblet cell differentiation through an EGFR-dependent mechanism (Anbazhagan2024PTGER4). These interactions highlight SPINK4's role in maintaining mucosal homeostasis and its potential therapeutic implications in inflammatory bowel diseases.


## References


[1. (Chen2021High) Tzu-Ju Chen, Yu-Feng Tian, Chia-Lin Chou, Ti-Chun Chan, Hong-Lin He, Wan-Shan Li, Hsin-Hwa Tsai, Chien-Feng Li, and Hong-Yue Lai. High spink4 expression predicts poor outcomes among rectal cancer patients receiving ccrt. Current Oncology, 28(4):2373–2384, June 2021. URL: http://dx.doi.org/10.3390/curroncol28040218, doi:10.3390/curroncol28040218. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/curroncol28040218)

[2. (Hu2023SPINK4) Bang-li Hu, Yi-xin Yin, Ke-zhi Li, Si-qi Li, and Zhao Li. Spink4 promotes colorectal cancer cell proliferation and inhibits ferroptosis. BMC Gastroenterology, April 2023. URL: http://dx.doi.org/10.1186/s12876-023-02734-2, doi:10.1186/s12876-023-02734-2. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12876-023-02734-2)

[3. (Wang2024Therapeutic) Ying Wang, Jing Han, Guang Yang, Shuhui Zheng, Gaoshi Zhou, Xinjuan Liu, Xiaocang Cao, Guang Li, Bowen Zhang, Zhuo Xie, Li Li, Mudan Zhang, Xiaoling Li, Minhu Chen, and Shenghong Zhang. Therapeutic potential of the secreted kazal-type serine protease inhibitor spink4 in colitis. Nature Communications, July 2024. URL: http://dx.doi.org/10.1038/s41467-024-50048-y, doi:10.1038/s41467-024-50048-y. This article has 0 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-024-50048-y)

[4. (Anbazhagan2024PTGER4) Murugadas Anbazhagan, Garima Sharma, Shanta Murthy, Sushma Chowdary Maddipatla, Vasantha L. Kolachala, Anne Dodd, Amanda Randunne, David J. Cutler, Subra Kugathasan, and Jason D. Matthews. Ptger4 signaling regulates class iia hdac function and spink4 mrna levels in rectal epithelial cells. Cell Communication and Signaling, October 2024. URL: http://dx.doi.org/10.1186/s12964-024-01879-1, doi:10.1186/s12964-024-01879-1. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12964-024-01879-1)

[5. (Wapenaar2007The) Martin C. Wapenaar, Alienke J. Monsuur, Jos Poell, Ruben van ‘t Slot, Jos W. R. Meijer, Gerrit A. Meijer, Chris J. Mulder, Maria Luisa Mearin, and Cisca Wijmenga. The spink gene family and celiac disease susceptibility. Immunogenetics, February 2007. URL: http://dx.doi.org/10.1007/s00251-007-0199-5, doi:10.1007/s00251-007-0199-5. This article has 38 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00251-007-0199-5)

[6. (Wang2019Downregulated) Xiaojie Wang, Qian Yu, Waleed M. Ghareeb, Yiyi Zhang, Xingrong Lu, Ying Huang, Shenghui Huang, Yanwu Sun, Jiayi Lin, Jin Liu, and Pan Chi. Downregulated spink4 is associated with poor survival in colorectal cancer. BMC Cancer, December 2019. URL: http://dx.doi.org/10.1186/s12885-019-6484-5, doi:10.1186/s12885-019-6484-5. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12885-019-6484-5)